Corporate
Cardiff Oncology Crashes 35% Despite Strong Phase 2 Data as CEO and CFO Depart
4d ago
You're signed outSign in or to get full access.
CO
Cardiff Oncology (CRDF)·Earnings Reports
Q4 2024
View earnings summary and analysis
Q3 2024
View earnings summary and analysis
Q2 2019
View earnings summary and analysis
Q1 2019
View earnings summary and analysis
Research analysts covering Cardiff Oncology.
